摘要
T2DM和阻塞性睡眠呼吸暂停综合征(OSAS)均是具有潜在危险的现代常见病,并常常在肥胖病人中同时存在。本文报告1例肥胖T2DM伴OSAS的患者,经人胰高糖素样肽-1类似物(利拉鲁肽)联合二甲双胍治疗3个月,血糖控制平稳、体重下降。该治疗方案为解决此类患者的问题提供了新的选择。
Both type 2 diabetes mellitus （T2DM） and obstructive sleep apnea syndrome （OSAS） are common diseases having high potential hazards and clinically they are always co-existing, especially in obese patients. In this report, an obese patient with T2DM and OSAS was treated with human glucagonlike peptide-1 analogue liraglutide plus metformin for 3 months, and the effect was good in glycemic control and weight loss. Such a successful treatment may provide a new option for treating the similar patients.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2012年第6期469-470,共2页
Chinese Journal of Diabetes
作者简介
通讯作者：朱梅，E-mail：meichuqin@yahoo．com．cn
